News Focus
News Focus
Followers 71
Posts 4827
Boards Moderated 0
Alias Born 01/24/2004

Re: cjgaddy post# 221526

Monday, 06/15/2015 12:12:40 PM

Monday, June 15, 2015 12:12:40 PM

Post# of 347009
PPHM SAB’r Dr.Xianming.Huang(Brekken Lab) speaks tonight at Gordon-Research-Conf., Biddeford ME

Jun14–19 2015: “GRC: Apoptotic Cell Recognition & Clearance: Physiological Significance & Pathological Consequences”, Biddeford ME
GRC = Gordon Research Conferences (Univ. of New England) http://www.grc.org
”This 7th meeting of the Apoptotic Cell Recognition & Clearance Gordon Research Conf. will explore molecular details of apoptotic cell recognition and clearance mechanisms throughout evolution, including apoptotic immune regulation. We also will focus on the pathogenic subversion of mechanisms of apoptotic cell clearance. This meeting will bring together investigators who are at the forefront of these fields to present and discuss new findings & important issues…”
• Peregrine is the only corporate contributor to this conference: ”Generous financial support from Peregrine Pharmaceuticals is in memory of Dr. Philip E. Thorpe.” [Dr. Thorpe spoke & chaired at prior GRC’s many times before his passing on 3-30-13.]
Conf: http://www.grc.org/programs.aspx?id=13127
JUNE15 SESSION 7:30-9:30pm “Consequences of Lipid Alterations for Apoptotic Cell Clearance”
…Discussion Leader: Christopher Gregory (Univ. of Edinburgh, UK)
• 7:30-7:55pm Ian Dransfield (Univ/Edinburgh UK), "Protein S Binding to Apoptotic Cells & Subsequent Phagocytosis by Macrophages"
• 8:10-8:35pm Raymond Birge (Rutgers NJ Med-School), "Apoptotic Cell Recognition Receptors, Tyro3/Axl/Mer, Demonstrate Distinct Patterns of Ligand Recognition & Biological Function"
• June15 8:50-9:15pm Xianming Huang (UTSW-MC/Dallas – PPHM SAB/Brekken-Lab), "Phosphatidylserine-Targeting Antibodies Overcome Tumor Immunosuppression & Synergize with Immune Checkpoint Blockade"

= = = = = = = = = = = =KNOWN UPCOMING:
Jun15: GRC’s “7th Apoptotic Cell Recognition & Clearance Conf.”, Biddeford ME http://www.grc.org/programs.aspx?id=13127
…8:50-9:15pm: Xianming Huang (UTSW), “PS-Targeting Antibodies Overcome Tumor Immunosuppression & Synergize with Immune Checkpoint Blockade"

~Jul13: FY'15/Q4 (fye 4-30-15) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm

Jun15-18/Avid/Booth533: BIO Intl. Convention, Philadelphia http://convention.bio.org/2015

Aug26: CHI’s 10th Annual Immunotherapy & Vaccine Summit (IMVACS), Boston http://tinyurl.com/lfdoksl
… 9-9:30 Jeff T. Hutchins (VP/Preclin-Res.): “Expansion and Activation of T Cells via the Targeting of the Immunosuppressive Ligand PS: Combination Strategy with Conventional, Targeted, and Checkpoint Inhibitor Therapy”

Sep6-9: IASLC’s 16th World Conf. on Lung Cancer”, Denver http://tinyurl.com/qdteoc8
…Peregrine Exhibiting, Booth #1724 (KOL/SAB Dr. David Carbone will be President of IASLC eff. 9-2015)

Oct26-29/Avid/Booth909: IBC's BioProcess Intl. Conf. & Exhib, Boston http://www.ibclifesciences.com/BPI

Dec7-10/Avid/Booth307: IBC's Antibody Eng. & Therapeutics, SanDiego http://www.ibclifesciences.com/AntibodyEng

Mar15-17 2016: “Immune Checkpoint Inhibitors Conf.”, Boston http://immune-checkpoint.com (Peregrine is 1 of 4 Corp. Sponsors)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y